532 related articles for article (PubMed ID: 24578320)
1. What is the best treatment for patients with human papillomavirus-positive and -negative oropharyngeal cancer?
Urban D; Corry J; Rischin D
Cancer; 2014 May; 120(10):1462-70. PubMed ID: 24578320
[TBL] [Abstract][Full Text] [Related]
2. Human papillomavirus as a marker of the natural history and response to therapy of head and neck squamous cell carcinoma.
Ang KK; Sturgis EM
Semin Radiat Oncol; 2012 Apr; 22(2):128-42. PubMed ID: 22385920
[TBL] [Abstract][Full Text] [Related]
3. Induction chemotherapy followed by concurrent chemoradiotherapy for advanced stage oropharyngeal squamous cell carcinoma with HPV and P16 testing.
Flavill E; Fang YV; Miles B; Truelson J; Perkins S
Ann Otol Rhinol Laryngol; 2014 May; 123(5):365-73. PubMed ID: 24687594
[TBL] [Abstract][Full Text] [Related]
4. Human papillomavirus DNA detection in fine-needle aspirates as indicator of human papillomavirus-positive oropharyngeal squamous cell carcinoma: A prospective study.
Sivars L; Landin D; Haeggblom L; Tertipis N; Grün N; Bersani C; Marklund L; Ghaderi M; Näsman A; Ramqvist T; Nordfors C; Munck-Wikland E; Tani E; Dalianis T
Head Neck; 2017 Mar; 39(3):419-426. PubMed ID: 27898186
[TBL] [Abstract][Full Text] [Related]
5. Human papillomavirus prevalence and prognostic implication in oropharyngeal squamous cell carcinomas.
Melkane AE; Auperin A; Saulnier P; Lacroix L; Vielh P; Casiraghi O; Msakni I; Drusch F; Temam S
Head Neck; 2014 Feb; 36(2):257-65. PubMed ID: 23728782
[TBL] [Abstract][Full Text] [Related]
6. Bcl2 and human papilloma virus 16 as predictors of outcome following concurrent chemoradiation for advanced oropharyngeal cancer.
Nichols AC; Finkelstein DM; Faquin WC; Westra WH; Mroz EA; Kneuertz P; Begum S; Michaud WA; Busse PM; Clark JR; Rocco JW
Clin Cancer Res; 2010 Apr; 16(7):2138-46. PubMed ID: 20233885
[TBL] [Abstract][Full Text] [Related]
7. HPV-associated neuroendocrine carcinoma of the oropharynx: a rare new entity with potentially aggressive clinical behavior.
Kraft S; Faquin WC; Krane JF
Am J Surg Pathol; 2012 Mar; 36(3):321-30. PubMed ID: 22301491
[TBL] [Abstract][Full Text] [Related]
8. Squamous cell carcinoma metastatic to neck from an unknown primary: the potential impact of modern pathologic evaluation on perceived incidence of human papillomavirus-positive oropharyngeal carcinoma prior to 1970.
Chenevert J; Seethala RR; Barnes EL; Chiosea SI
Laryngoscope; 2012 Apr; 122(4):793-6. PubMed ID: 22252715
[TBL] [Abstract][Full Text] [Related]
9. HPV in oropharyngeal cancer: the basics to know in clinical practice.
Elrefaey S; Massaro MA; Chiocca S; Chiesa F; Ansarin M
Acta Otorhinolaryngol Ital; 2014 Oct; 34(5):299-309. PubMed ID: 25709145
[TBL] [Abstract][Full Text] [Related]
10. Use of tissue microarray to facilitate oncology research.
Gouveris P; Weinberger PM; Psyrri A
Methods Mol Biol; 2010; 632():239-50. PubMed ID: 20217582
[TBL] [Abstract][Full Text] [Related]
11. The increasing clinical relevance of human papillomavirus type 16 (HPV-16) infection in oropharyngeal cancer.
Shaw R; Robinson M
Br J Oral Maxillofac Surg; 2011 Sep; 49(6):423-9. PubMed ID: 20727631
[TBL] [Abstract][Full Text] [Related]
12. Refining the diagnosis of oropharyngeal squamous cell carcinoma using human papillomavirus testing.
Robinson M; Sloan P; Shaw R
Oral Oncol; 2010 Jul; 46(7):492-6. PubMed ID: 20227331
[TBL] [Abstract][Full Text] [Related]
13. A Comparison of Clinical Outcomes Between HPV Positive and HPV Negative Squamous Cell Carcinomas of the Oropharynx.
Sanders E
ORL Head Neck Nurs; 2016; 34(2):11-4. PubMed ID: 27305732
[TBL] [Abstract][Full Text] [Related]
14. HPV-positive head and neck tumours, a distinct clinical entity.
Nevens D; Nuyts S
B-ENT; 2015; 11(2):81-7. PubMed ID: 26563006
[TBL] [Abstract][Full Text] [Related]
15. Oropharyngeal cancer - is it time to change management according to human papilloma virus status?
Mehanna H; Olaleye O; Licitra L
Curr Opin Otolaryngol Head Neck Surg; 2012 Apr; 20(2):120-4. PubMed ID: 22327790
[TBL] [Abstract][Full Text] [Related]
16. Contemporary management of oropharyngeal cancer: anatomy and physiology of the oropharynx.
Duvvuri U; Myers JN
Curr Probl Surg; 2009 Feb; 46(2):119-84. PubMed ID: 19111679
[No Abstract] [Full Text] [Related]
17. Human papilloma virus in locally advanced stage III/IV squamous cell cancer of the oropharynx and impact on choice of therapy.
Ihloff AS; Petersen C; Hoffmann M; Knecht R; Tribius S
Oral Oncol; 2010 Oct; 46(10):705-11. PubMed ID: 20843732
[TBL] [Abstract][Full Text] [Related]
18. Effect of human papillomavirus on patterns of distant metastatic failure in oropharyngeal squamous cell carcinoma treated with chemoradiotherapy.
Trosman SJ; Koyfman SA; Ward MC; Al-Khudari S; Nwizu T; Greskovich JF; Lamarre ED; Scharpf J; Khan MJ; Lorenz RR; Adelstein DJ; Burkey BB
JAMA Otolaryngol Head Neck Surg; 2015 May; 141(5):457-62. PubMed ID: 25742025
[TBL] [Abstract][Full Text] [Related]
19. Atypical clinical behavior of p16-confirmed HPV-related oropharyngeal squamous cell carcinoma treated with radical radiotherapy.
Huang SH; Perez-Ordonez B; Liu FF; Waldron J; Ringash J; Irish J; Cummings B; Siu LL; Kim J; Weinreb I; Hope A; Gullane P; Brown D; Shi W; O'Sullivan B
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):276-83. PubMed ID: 20950953
[TBL] [Abstract][Full Text] [Related]
20. High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma.
Licitra L; Perrone F; Bossi P; Suardi S; Mariani L; Artusi R; Oggionni M; Rossini C; Cantù G; Squadrelli M; Quattrone P; Locati LD; Bergamini C; Olmi P; Pierotti MA; Pilotti S
J Clin Oncol; 2006 Dec; 24(36):5630-6. PubMed ID: 17179101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
